Have a question?
Open from 8am to 7pm Monday to FridayCall customer services
0345 54 32 600

Perspective Therapeutics (CATX)

Common Stock

Sell: $2.65|Buy: $2.76|Change: 0.01 (0.37%)

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Company profile

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Address

Sector

Healthcare

Forecast key dates

Name	Key Date

Previous key dates

Name	Key Date

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.